Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral vector targeting.

K W Peng1, S J Russell

  • 1Molecular Medicine Program Mayo Clinic 200 First Street SW, Rochester, MN 55905, USA.

Current Opinion in Biotechnology
|October 6, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PIWIs, piRNAs and Retrotransposons: Complex battles during reprogramming in gametes and early embryos.

Reproduction in domestic animals = Zuchthygiene·2017
Same author

High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma.

Blood cancer journal·2017
Same author

Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains.

Leukemia·2017
Same author

Pomalidomide-dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial.

Leukemia·2017
Same author

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma.

Blood cancer journal·2017
Same author

Natural history of t(11;14) multiple myeloma.

Leukemia·2017
Same journal

Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design.

Current opinion in biotechnology·2026
Same journal

Medicinal plants fermentation: current knowledge and perspectives.

Current opinion in biotechnology·2026
Same journal

Fermented foods: lessons learned from metagenomics.

Current opinion in biotechnology·2026
Same journal

Microfluidic platforms for the transient transfection of mammalian cells: recent developments and challenges.

Current opinion in biotechnology·2026
Same journal

Harvesting insights from recent advances in yeast genomics for predictable and precision wine fermentation.

Current opinion in biotechnology·2026
Same journal

Minimal enzyme cascades for the aromatic-to-aromatic upgrading of lignin monomers.

Current opinion in biotechnology·2026
See all related articles

Viral vector targeting is rapidly advancing with new methods like bifunctional crosslinkers and peptide insertions. These innovations enhance precision for applications including cancer therapy and gene delivery.

Area of Science:

  • Biotechnology and Gene Therapy
  • Molecular Virology

Background:

  • Viral vectors are crucial tools in gene therapy and biomedical research.
  • Precise targeting of viral vectors is essential for efficacy and safety.
  • Current limitations in targeting necessitate innovative strategies.

Purpose of the Study:

  • To review recent advancements in viral vector targeting strategies.
  • To highlight novel approaches for enhancing vector specificity and function.
  • To discuss the therapeutic potential of targeted viral vectors.

Main Methods:

  • Utilizing bifunctional crosslinkers for adenoviral and retroviral vector targeting.
  • Determining crystal structures of viral receptor-binding domains.
  • Engineering viral coat proteins to incorporate targeting peptides and binding domains.

Related Experiment Videos

  • Developing host range restriction and protease-activated targeting mechanisms.
  • Employing vector display libraries for targeted vector selection.

    • Main Results:

    • Successful application of bifunctional crosslinkers for targeted delivery.
    • Structural insights into adenoviral and retroviral receptor interactions.
    • Demonstrated feasibility of inserting targeting moieties into viral coat proteins.
    • Development of novel host-range and protease-activated targeting systems.
    • Emerging promise of targeted replication-competent vectors in anti-cancer therapies.

    Conclusions:

    • Significant progress has been made in the field of viral vector targeting.
    • New strategies offer enhanced control over vector tropism and payload delivery.
    • Targeted viral vectors hold considerable potential for diverse therapeutic applications, particularly in oncology.